drugset / Trial / NCT03798912
A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to ascertain the safety, tolerability and performance of the RaniPill capsule in healthy volunteers
Timeline
- Start
- 2019-07-09
- Primary completion
- 2020-02-17
- Completion
- 2020-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | 100 ug | Intravenous |
Indications
No indication recorded.